212 related articles for article (PubMed ID: 19962997)
1. Pharmacological activity of C10-substituted analogs of the high-affinity kainate receptor agonist dysiherbaine.
Lash-Van Wyhe LL; Postila PA; Tsubone K; Sasaki M; Pentikäinen OT; Sakai R; Swanson GT
Neuropharmacology; 2010 Mar; 58(3):640-9. PubMed ID: 19962997
[TBL] [Abstract][Full Text] [Related]
2. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
[TBL] [Abstract][Full Text] [Related]
3. Divergent pharmacological activity of novel marine-derived excitatory amino acids on glutamate receptors.
Sanders JM; Ito K; Settimo L; Pentikäinen OT; Shoji M; Sasaki M; Johnson MS; Sakai R; Swanson GT
J Pharmacol Exp Ther; 2005 Sep; 314(3):1068-78. PubMed ID: 15914675
[TBL] [Abstract][Full Text] [Related]
4. Novel analogs and stereoisomers of the marine toxin neodysiherbaine with specificity for kainate receptors.
Lash LL; Sanders JM; Akiyama N; Shoji M; Postila P; Pentikäinen OT; Sasaki M; Sakai R; Swanson GT
J Pharmacol Exp Ther; 2008 Feb; 324(2):484-96. PubMed ID: 18032572
[TBL] [Abstract][Full Text] [Related]
5. Glutamate receptor trafficking: endoplasmic reticulum quality control involves ligand binding and receptor function.
Mah SJ; Cornell E; Mitchell NA; Fleck MW
J Neurosci; 2005 Mar; 25(9):2215-25. PubMed ID: 15745947
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of recombinant and native GluK3-containing kainate receptors.
Perrais D; Pinheiro PS; Jane DE; Mulle C
Neuropharmacology; 2009 Jan; 56(1):131-40. PubMed ID: 18761361
[TBL] [Abstract][Full Text] [Related]
7. Determination of binding site residues responsible for the subunit selectivity of novel marine-derived compounds on kainate receptors.
Sanders JM; Pentikäinen OT; Settimo L; Pentikäinen U; Shoji M; Sasaki M; Sakai R; Johnson MS; Swanson GT
Mol Pharmacol; 2006 Jun; 69(6):1849-60. PubMed ID: 16537793
[TBL] [Abstract][Full Text] [Related]
8. Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7.
Cui C; Mayer ML
J Neurosci; 1999 Oct; 19(19):8281-91. PubMed ID: 10493729
[TBL] [Abstract][Full Text] [Related]
9. Differential activation of individual subunits in heteromeric kainate receptors.
Swanson GT; Green T; Sakai R; Contractor A; Che W; Kamiya H; Heinemann SF
Neuron; 2002 May; 34(4):589-98. PubMed ID: 12062042
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons.
Bleakman D; Ogden AM; Ornstein PL; Hoo K
Eur J Pharmacol; 1999 Aug; 378(3):331-7. PubMed ID: 10493110
[TBL] [Abstract][Full Text] [Related]
11. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine.
Frydenvang K; Lash LL; Naur P; Postila PA; Pickering DS; Smith CM; Gajhede M; Sasaki M; Sakai R; Pentikaïnen OT; Swanson GT; Kastrup JS
J Biol Chem; 2009 May; 284(21):14219-29. PubMed ID: 19297335
[TBL] [Abstract][Full Text] [Related]
12. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.
Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E
Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679
[TBL] [Abstract][Full Text] [Related]
13. Exploring kainate receptor pharmacology using molecular dynamics simulations.
Postila PA; Swanson GT; Pentikäinen OT
Neuropharmacology; 2010 Feb; 58(2):515-27. PubMed ID: 19737573
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
Jane DE; Hoo K; Kamboj R; Deverill M; Bleakman D; Mandelzys A
J Med Chem; 1997 Oct; 40(22):3645-50. PubMed ID: 9357531
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of the potent epileptogenic amino acid dysiherbaine, a novel glutamate receptor agonist isolated from the marine sponge Dysidea herbacea.
Sakai R; Swanson GT; Shimamoto K; Green T; Contractor A; Ghetti A; Tamura-Horikawa Y; Oiwa C; Kamiya H
J Pharmacol Exp Ther; 2001 Feb; 296(2):650-8. PubMed ID: 11160654
[TBL] [Abstract][Full Text] [Related]
16. Design, total synthesis, and biological evaluation of neodysiherbaine A derivative as potential probes.
Sasaki M; Tsubone K; Shoji M; Oikawa M; Shimamoto K; Sakai R
Bioorg Med Chem Lett; 2006 Nov; 16(22):5784-7. PubMed ID: 16949819
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
Mayer ML
Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240
[TBL] [Abstract][Full Text] [Related]
18. GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors.
Paternain AV; Herrera MT; Nieto MA; Lerma J
J Neurosci; 2000 Jan; 20(1):196-205. PubMed ID: 10627597
[TBL] [Abstract][Full Text] [Related]
19. Structure and assembly mechanism for heteromeric kainate receptors.
Kumar J; Schuck P; Mayer ML
Neuron; 2011 Jul; 71(2):319-31. PubMed ID: 21791290
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
Mayer ML; Ghosal A; Dolman NP; Jane DE
J Neurosci; 2006 Mar; 26(11):2852-61. PubMed ID: 16540562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
